JAK2 and graft versus host disease: Given that both IFNGR and IL-6R signaling are mediated by both JAK1 and JAK2, we additionally confirmed that the balanced inhibition of JAK1/JAK2 is important to block both IFNGR and IL-6R signaling for optimal GvHD prevention [13,14].